What to know about FDA’s review of new Zyn advertising proposal – One America News Network

0
85

By MATTHEW PERRONE
Updated 7:00 AM PST, January 22, 2026

Containers of Zyn, a smokeless nicotine pouch, at a newsstand on Feb. 23, 2024, in New York. (AP Photo/Bebeto Matthews, File)

WASHINGTON (AP) — Americans who smoke may soon be hearing a lot more about Zyn, the flavored nicotine pouches that have generated billions in sales while going viral on social media.

The Food and Drug Administration is holding a public meeting Thursday to consider whether Philip Morris International can advertise its pouches as a less-harmful alternative for adults who currently smoke cigarettes.

Government documents posted before the meeting suggest FDA regulators are leaning toward approving the company’s request. But the meeting will give an outside panel of health experts a chance to weigh in and ask questions of both the company and the agency.

Zyn contains nicotine powder…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here